Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case

Early access programs (EAPs) generally refer to patient access to medicines/indications before marketing authorization, possibly extended to price and reimbursement approval. These programs include compassionate use, which is usually covered by pharmaceutical companies, and EAPs reimbursed by third-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarantola, Alice, Otto, Monica Hildegard, Armeni, Patrizio, Costa, Francesco, Malandrini, Francesco, Jommi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193685/
https://www.ncbi.nlm.nih.gov/pubmed/37198599
http://dx.doi.org/10.1186/s40545-023-00570-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193685/
https://www.ncbi.nlm.nih.gov/pubmed/37198599
http://dx.doi.org/10.1186/s40545-023-00570-z

Ejemplares similares